Testing effectiveness (Phase 2)Ended earlyNCT01322815What this trial is testingA Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRIWho this might be right forColon Cancer Georgetown University 11
Early research (Phase 1)Study completedNCT00361049What this trial is testingDonor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell TransplantWho this might be right forCancer Case Comprehensive Cancer Center 49
Early research (Phase 1)Looking for participantsNCT05338658What this trial is testingStudy of PAT in Patients With Solid Tumor CancersWho this might be right forMetastasisSolid Tumor Masonic Cancer Center, University of Minnesota 21
Testing effectiveness (Phase 2)Study completedNCT00988858What this trial is testingAdvanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 55
Not applicableUnknownNCT03451643What this trial is testingStenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IVWho this might be right forColorectal Neoplasm University of Roma La Sapienza 50
Early research (Phase 1)WithdrawnNCT04602117What this trial is testingISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerWho this might be right forHER2-positive Breast CancerHER2 LowSYD-985+24 more QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Active Not RecruitingNCT04599140What this trial is testingSX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 TrialWho this might be right forMetastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+18 more M.D. Anderson Cancer Center 51
Early research (Phase 1)Study completedNCT03009240What this trial is testingPevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia+3 more City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT04187833What this trial is testingNivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness GenesWho this might be right forMetastatic or Unresectable Melanoma Case Comprehensive Cancer Center 8
Large-scale testing (Phase 3)Active Not RecruitingNCT04776655What this trial is testingStudy in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaBWho this might be right forColorectal CancerMetastatic Colorectal CancerRAS Mutation Azienda USL Reggio Emilia - IRCCS 280
Testing effectiveness (Phase 2)Looking for participantsNCT07636785What this trial is testingAnd 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid TumorsWho this might be right forHepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more VM Discovery, Inc. 111
Testing effectiveness (Phase 2)Study completedNCT00711243What this trial is testingDocetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid TumorWho this might be right forGastric CancerUnspecified Adult Solid Tumor, Protocol Specific Northwestern University 59
Early research (Phase 1)Study completedNCT03010176What this trial is testingStudy of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)Who this might be right forSolid TumorsLymphoma Merck Sharp & Dohme LLC 156
Testing effectiveness (Phase 2)Study completedNCT02784652What this trial is testingEfficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal TumorsWho this might be right forBone MetastasisGastrointestinal Cancer Severance Hospital 60
Large-scale testing (Phase 3)Active Not RecruitingNCT03178552What this trial is testingEvaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03149549What this trial is testingPROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid TumorsWho this might be right forSolid Tumor, AdultBreast CancerNon Small Cell Lung Cancer+2 more CytomX Therapeutics 99
Not applicableStudy completedNCT02106858What this trial is testingStivarga Regulatory Post-Marketing Surveillance Study in KoreaWho this might be right forColorectal Neoplasms Bayer 316
Not applicableStudy completedNCT05174026What this trial is testing18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic RadiosurgeryWho this might be right forMetastatic Malignant NeoplasmMetastatic Malignant Neoplasm in the Bone M.D. Anderson Cancer Center 10
Not applicableStudy completedNCT00634426What this trial is testingSurgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord CompressionWho this might be right forMetastatic Epidural Spinal Cord Compression AOSpine North America Research Network 163
Early research (Phase 1)Looking for participantsNCT06349408What this trial is testingIBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Solid Tumor Fortvita Biologics (USA)Inc. 250